synkinase 产品代理
synkinase 产品代理
目前有150多种激酶靶向药物正在临床试验或研发中。SYNkinase有许多此类化合物可供出售，以及文献中描述的大量抑制剂，如GPCR、TGFβ、MAP激酶、细胞周期和表观遗传学抑制剂。
SYNkinase
small molecule inhibitors
SYNkinase’s mission is to provide life-science researchers with access to the world’s most up-to-date library of kinase inhibitors, and small molecule inhibitors of important therapeutic proteins, for drug-discovery research use. With guidance from our founders, who include kinase biology scientists and expert medicinal and synthetic chemists, we have created a library of potent, pure and research-relevant small molecules.
There are more than 150 kinase targeted drugs in clinical trials or development at present. SYNkinase has many of these compounds available for sale as well as a large range of inhibitors described in the literature such as GPCR, TGF-Beta, MAP Kinase, Cell Cycle and epigenetic inhibitors.
SYNkinase is also a primary source manufacturer, backed by a well-respected chemistry research organisation. If we don’t have your preferred small molecule in our catalogue, we can source or manufacture to your custom specifications.
